Top segments and regional performance

Last year, the company generated 7.50 k USD, the most of which — 7.50 k USD — came from its top-performing segment, Screening and Genetically Engineering Microbes of the Skin, compared to 686.00 k USD the previous year. The greatest contribution came from United States, which accounted for 7.50 k USD last year, with 686.00 k USD the year before.